ASRGL1

asparaginase and isoaspartyl peptidase 1

Basic information

Region (hg38): 11:62337448-62393412

Links

ENSG00000162174NCBI:80150OMIM:609212HGNC:16448Uniprot:Q7L266AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

  • inherited retinal dystrophy (Limited), mode of inheritance: AR

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the ASRGL1 gene.

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the ASRGL1 gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous
2
clinvar
63
clinvar
7
clinvar
72
missense
120
clinvar
3
clinvar
1
clinvar
124
nonsense
2
clinvar
2
start loss
0
frameshift
6
clinvar
6
inframe indel
2
clinvar
2
splice donor/acceptor (+/-2bp)
1
clinvar
1
splice region
6
4
2
12
non coding
1
clinvar
25
clinvar
2
clinvar
28
Total 0 0 134 91 10

Variants in ASRGL1

This is a list of pathogenic ClinVar variants found in the ASRGL1 region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position Type Phenotype Significance ClinVar
11-62337969-T-C ASRGL1-related disorder Benign (Nov 04, 2019)3059422
11-62337981-A-G Uncertain significance (Jun 20, 2022)1524500
11-62337990-G-A not specified Uncertain significance (Jul 07, 2023)839389
11-62337993-G-A Uncertain significance (Mar 04, 2023)2980587
11-62337998-C-T Likely benign (Mar 28, 2022)1963383
11-62338001-C-T Benign (Jan 24, 2024)1167856
11-62338004-C-T Likely benign (Feb 10, 2022)1144952
11-62338007-C-T Likely benign (Jan 17, 2024)1591635
11-62338008-G-A Uncertain significance (Sep 02, 2021)839509
11-62338011-G-T not specified Uncertain significance (Mar 22, 2023)1063465
11-62338014-G-A Uncertain significance (Jan 19, 2021)1404484
11-62338024-C-G Uncertain significance (Jun 22, 2022)1503938
11-62338027-A-G not specified Uncertain significance (May 08, 2024)2971348
11-62338033-G-A not specified Uncertain significance (Dec 13, 2023)969179
11-62338033-G-T Uncertain significance (Nov 25, 2023)2699113
11-62338044-G-A Uncertain significance (Sep 24, 2021)1382875
11-62338047-C-T Uncertain significance (Feb 03, 2022)1035687
11-62338053-G-A Uncertain significance (Feb 18, 2022)1952128
11-62338053-G-T Uncertain significance (Oct 10, 2023)1933545
11-62338055-C-T Uncertain significance (Feb 05, 2022)1025801
11-62338059-G-A Uncertain significance (Apr 08, 2021)1524258
11-62338062-A-G not specified Uncertain significance (Apr 06, 2024)1917418
11-62338073-C-T Likely benign (Aug 10, 2023)1089241
11-62338073-C-CG Uncertain significance (Oct 10, 2021)1475398
11-62338074-G-A ASRGL1-related disorder Benign (Dec 31, 2023)1170709

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
ASRGL1protein_codingprotein_codingENST00000415229 655963
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
0.00002760.5541256870611257480.000243
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense0.2031771850.9580.00001041980
Missense in Polyphen7379.0110.92392781
Synonymous-0.3888075.71.060.00000493634
Loss of Function0.674810.30.7744.32e-7141

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.0002820.000275
Ashkenazi Jewish0.000.00
East Asian0.0004350.000435
Finnish0.00004630.0000462
European (Non-Finnish)0.0003980.000396
Middle Eastern0.0004350.000435
South Asian0.00007090.0000653
Other0.000.00

dbNSFP

Source: dbNSFP

Function
FUNCTION: Has both L-asparaginase and beta-aspartyl peptidase activity. May be involved in the production of L-aspartate, which can act as an excitatory neurotransmitter in some brain regions. Is highly active with L-Asp beta-methyl ester. Besides, has catalytic activity toward beta-aspartyl dipeptides and their methyl esters, including beta-L-Asp-L-Phe, beta-L-Asp-L-Phe methyl ester (aspartame), beta-L-Asp-L-Ala, beta-L-Asp-L-Leu and beta-L- Asp-L-Lys. Does not have aspartylglucosaminidase activity and is inactive toward GlcNAc-L-Asn. Likewise, has no activity toward glutamine. {ECO:0000269|PubMed:19839645}.;
Pathway
Ammonia Recycling;Hypoacetylaspartia;Aspartate Metabolism;Canavan Disease;Histidine, lysine, phenylalanine, tyrosine, proline and tryptophan catabolism;Metabolism of amino acids and derivatives;Phenylalanine and tyrosine catabolism;Metabolism;asparagine degradation (Consensus)

Recessive Scores

pRec
0.278

Intolerance Scores

loftool
0.145
rvis_EVS
-0.31
rvis_percentile_EVS
31.93

Haploinsufficiency Scores

pHI
0.0944
hipred
N
hipred_score
0.300
ghis
0.539

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
S
essential_gene_gene_trap
N
gene_indispensability_pred
N
gene_indispensability_score
0.0643

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
Asrgl1
Phenotype

Zebrafish Information Network

Gene name
asrgl1
Affected structure
whole organism
Phenotype tag
abnormal
Phenotype quality
deformed

Gene ontology

Biological process
proteolysis;L-phenylalanine catabolic process;asparagine catabolic process via L-aspartate;protein maturation
Cellular component
photoreceptor inner segment;nucleus;cytoplasm;cytosol
Molecular function
N4-(beta-N-acetylglucosaminyl)-L-asparaginase activity;asparaginase activity;beta-aspartyl-peptidase activity;hydrolase activity